1 insider bought €258k of shares over the last 90 days, the latest by Elsztain Alejandro Gustavo, filed 15 Oct 2026.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
21 of 21 declarations
At Cresud Inc, purchases and sales balance out by count, 10 each, but not in value: EUR 1,365,898 of purchases (median EUR 86,765) against EUR 279,654 of sales (median EUR 17,683). The three largest purchases date from May and June 2026: Eduardo S. Elsztain (Director) for EUR 528,563 on May 13, Alejandro Gustavo Elsztain for EUR 171,589 on June 5 and Saul Zang for EUR 155,508 on May 20. From May 13 to June 5, 2026, 3 insiders bought for EUR 936,379.
All the sales come from a single director, Fernando Adrian Elsztain, who signs 10 of the 21 filings: EUR 76,192 on June 11, 2026, EUR 69,826 on September 10, 2026 and EUR 35,807 on September 9, 2026. Alejandro Gustavo Elsztain signs 8, 7 of them purchases.
This US industrials company is valued at USD 790.8 million, with 16% held by the 4 insiders on record. The 21 filings were published from April 24, 2026 to October 15, 2026. The median publication delay is 2 days.
Insider filings
Over the last 90 days, 14 filings published between 30 July and 15 October 2026: 3 open-market purchases by insiders for €258k, 10 sales for €280k. 1 other filing (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Elsztain Fernando Adrian (Director), sales of €280k; Elsztain Alejandro Gustavo (Director), purchases of €258k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 16 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Jun 2025 | 914.16 bn ARS | 224.37 bn ARS | n.d. | 20-F |
| Jun 2024 | 959.36 bn ARS | 148.84 bn ARS | n.d. | 20-F |
| Jun 2023 | 986.27 bn ARS | 406.48 bn ARS | n.d. | 20-F |
| Jun 2022 | 767.70 bn ARS | 504.59 bn ARS | n.d. | 20-F |
| Jun 2021 | 149.93 bn ARS | -86.62 bn ARS | n.d. | 20-F |
Amounts in ARS, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.